More on ABVX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $112.70 |
|
|||
| Open | $110.75 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $111.34 | ||||
| Day Low | $108.83 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 822,813 | ||||
- Wedbush Starts Abivax (ABVX) at Underperform
- Form 6-K Abivax S.A. For: Feb 21
- Abivax (ABVX) Reiterated at Market Outperform by Citizens: Presented 22 Abstracts
- Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
- Form SCHEDULE 13G/A Abivax S.A. Filed by: Invus Global Management, LLC
- Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I
- Guggenheim Reiterates Abivax (ABVX) at Buy, 'ABVX remains as our Best Idea'
- Abivax shares trim gains after French Finance Ministry statement
- Abivax shares surge after report flags continued Eli Lilly takeover interest
- Abivax (ABVX) PT Raised to $145 at Morgan Stanley
Entities mentioned with ABVX
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Earnings | View Related Stories »
- Carl Icahn | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
